The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells
Open accessAbstract
Multidrug-resistant (MDR) tumors and cancer cell lines demonstrate a wide variety of biochemical changes. In this study we used drug-sensitive wild-type (wt) cancer cell lines and respective MDR subclones, and we demonstrate the accumulation of distinct lipids in MDR cells. These lipids were either absent or present at very low levels in drug-sensitive cells. The compounds, termed lipid-1 and lipid-2, migrated on thin-layer chromatography as a doublet. They could be radiolabeled by incubating MCF-7-AdrR (Adriamycin-resistant) breast cancer cells with [3H]serine, [3H]palmitic acid, or [3H]galactose. Utilization of these precursors by MCF-7-wt cells for synthesis of lipid-1 and -2 was minimal. Two inhibitors of sphingolipid biosynthesis, L-cycloserine and fumonisin B1, prevented the observed accumulation of the lipid compounds. An inhibitor of glucosylceramide synthesis, 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol, completely abolished the formation of lipid-1 and -2 in MCF-7-AdrR cells and, to a lesser extent, inhibited the formation of lactosylceramides and gangliosides. Utilizing mass spectrometry, the multidrug resistance-associated lipids were further characterized as monoglycosylceramides of two major species that contained either 16-carbon (palmitic) or 24-carbon (lignoceric and nervonic) fatty acids. The carbohydrate head group of glycosylceramides was identified as glucose, not galactose, thus designating the accumulated lipids as glucosylceramides. Incorporation of [3H]palmitic acid into glucosylceramide was strikingly higher (8-10 times) in MCF-7-AdrR cells compared with MCF-7-wt cells. Since the rate of glucosylceramide degradation in MCF-7-AdrR cells was not attenuated, accelerated glycosphingolipid synthesis in MDR cells is suggested. Glucosylceramide also accumulated in KB-V-1, a vinblastine-resistant epidermoid carcinoma but not in KB-3-1, drug-sensitive wt cells. MDR ovarian adenocarcinoma cells (NIH:OVCAR-3) also contained elevated levels of glucosylceramide. Our results demonstrate a correlation between cellular drug resistance and alterations in glucosylceramide metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Programmed Cell Death Induced by Ceramide
Obeid, L. M., Linardic, C. M., Karolak, L. A., & Hannun, Y. A. (1993) · Science · doi:10.1126/science.8456305 · Cited by 1,794
Glycosphingolipids in Cellular Interaction, Differentiation, and Oncogenesis
Hakomori, S. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.003505 · Cited by 1,644
Functions of Sphingolipids and Sphingolipid Breakdown Products in Cellular Regulation
Hannun, Y. A., & Bell, R. M. (1989) · Science · doi:10.1126/science.2643164 · Cited by 1,251
Wang, E., Norred, W. P., Bacon, C. W., Riley, R. T., & Merrill, A. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98712-0 · Cited by 1,113
Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., & Kolesnick, R. (1995) · Cell · doi:10.1016/0092-8674(95)90429-8 · Cited by 826
Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
Chin, K.-V., Ueda, K., Pastan, I., & Gottesman, M. M. (1992) · Science · doi:10.1126/science.1346476 · Cited by 726
Mechanism of multidrug resistance
Bradley, G., Juranka, P. F., & Ling, V. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90006-6 · Cited by 617
Phosphatidylcholine translocase: A physiological role for the mdr2 gene
Ruetz, S. (1994) · Cell · doi:10.1016/0092-8674(94)90446-4 · Cited by 599
Dressler, K. A., Mathias, S., & Kolesnick, R. N. (1992) · Science · doi:10.1126/science.1313189 · Cited by 440
Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer
Rogan, A. M., Hamilton, T. C., Young, R. C., Klecker, R. W., & Ozols, R. F. (1984) · Science · doi:10.1126/science.6372095 · Cited by 396
Biochemistry of lipids and membranes
(1986) · International Journal of Biochemistry · doi:10.1016/0020-711x(86)90300-9 · Cited by 301
Nilsson, O., & Svennerholm, L. T. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb07950.x · Cited by 283
P-glycoprotein, multidrug resistance and tumor progression
Bradley, G., & Ling, V. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689638 · Cited by 195
Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons
Harel, R., & Futerman, A. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85263-8 · Cited by 183
Regulation of Ion Channels by ABC Transporters That Secrete ATP
al-Awqati, Q. (1995) · Science · doi:10.1126/science.7543697 · Cited by 175
A Regulatory Role for Sphingolipids in Neuronal Growth
Schwarz, A., Rapaport, E., Hirschberg, K., & Futerman, A. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10990 · Cited by 161
Cell Cycle Arrest Induced by an Inhibitor of Glucosylceramide Synthase
Rani, S. C. S., Abe, A., Chang, Y., Rosenzweig, N., Saltiel, A. R., Radin, N. S., & Shayman, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2859 · Cited by 159
Acid β-Glucosidase: Enzymology and Molecular Biology of Gaucher Diseas
Grabowski, G. A., Gaft, S., Horowitz, M., & Kolodny, E. H. (1990) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239009090616 · Cited by 150
Merrill, A. H., & Wang, E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35713-7 · Cited by 146
Olivera, A., Buckley, N. E., & Spiegel, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35725-9 · Cited by 128
Drug resistance in Chinese hamster lung and mouse tumor cells.
Biedler, J. L., Td, C., Mb, M., Rh, P., & Spengler, B. A. (1983) · PubMed · Cited by 104
GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression
Thurin, J., Thurin, M., Herlyn, M., Elder, D. E., Steplewski, Z., Clark, W. H., & Koprowski, H. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)81522-8 · Cited by 85
Taki, T., Hirabayashi, Y., Ishikawa, H., Ando, S., Kon, K., Tanaka, Y., & Matsumoto, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35748-4 · Cited by 75
Nakamura, S., Kozutsumi, Y., Sun, Y., Miyake, Y., Fujita, T., & Kawasaki, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1255 · Cited by 75
Yan, J., Ilsley, D. D., Frohlick, C., Steet, R., Hall, E. T., Kuchta, R. D., & ̧on, P. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.22836 · Cited by 55
Chapter 19 Tumor gangliosides as targets for active specific immunotherapy of melanoma in man
Morton, D. L., Ravindranath, M. H., & Irie, R. F. (1994) · Progress in brain research · doi:10.1016/s0079-6123(08)61954-8 · Cited by 40
Mahdiyoun, S., Deshmukh, G. D., Abe, A., Radin, N. S., & Shayman, J. A. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90023-p · Cited by 10
Cited by
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 785
Raft ceramide in molecular medicine
Gulbins, E., & Kolesnick, R. (2003) · Oncogene · doi:10.1038/sj.onc.1207146 · Cited by 422
Mechanisms and strategies to overcome multiple drug resistance in cancer
Ozben, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.020 · Cited by 406
Intracellular signal transduction pathways activated by ceramide and its metabolites
Ruvolo, P. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00050-1 · Cited by 355
Metadata
- Authors
- Lavie, Y., Cao, H.-T., Bursten, S. L., Giuliano, A. E., & Cabot, M. C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-08
- Volume
- 271
- Issue
- 32
- Pages
- 19530-19536
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2002244693
- Cited by
- 340
- References
- 30
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.